Tarantini G, Tang G, Nai Fovino L, Blackman D, Van Mieghem NM, Kim WK, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery. EuroIntervention. 2023;19:37–52. https://doi.org/10.4244/eij-d-22-00958.
Article PubMed PubMed Central Google Scholar
Yamamoto M, Otsuka T, Shimura T, Yamaguchi R, Adachi Y, Kagase A, et al. Incidence, timing, and causes of late bleeding after TAVR in an Asian cohort. JACC Asia. 2022;2:622–32. https://doi.org/10.1016/j.jacasi.2022.04.007.
Article PubMed PubMed Central Google Scholar
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–227. https://doi.org/10.1161/cir.0000000000000923.
Persits I, Layoun H, Kondoleon NP, Spilias N, Badwan O, Sipko J, et al. Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement. Eur Heart J. 2024;45:1890–900. https://doi.org/10.1093/eurheartj/ehae019.
Patterson T, Clayton T, Dodd M, Khawaja Z, Morice MC, Wilson K, et al. ACTIVATION (percutaneous coronary intervention prior to transcatheter aortic valve implantation): a randomized clinical trial. JACC Cardiovasc Interv. 2021;14:1965–74. https://doi.org/10.1016/j.jcin.2021.06.041.
Altibi AM, Ghanem F, Hammad F, Patel J, Song HK, Golwala H, et al. Clinical outcomes of revascularization with percutaneous coronary intervention prior to transcatheter aortic valve replacement: a comprehensive meta-analysis. Curr Probl Cardiol. 2022;47: 101339. https://doi.org/10.1016/j.cpcardiol.2022.101339.
Ochiai T, Chakravarty T, Yoon SH, Kaewkes D, Flint N, Patel V, et al. Coronary access after TAVR. JACC Cardiovasc Interv. 2020;13:693–705. https://doi.org/10.1016/j.jcin.2020.01.216.
Barbanti M, Costa G, Picci A, Criscione E, Reddavid C, Valvo R, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC Cardiovasc Interv. 2020;13:2542–55. https://doi.org/10.1016/j.jcin.2020.07.006.
Vilalta V, Asmarats L, Ferreira-Neto AN, Maes F, de Freitas Campos Guimarães L, Couture T, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2523–33. https://doi.org/10.1016/j.jcin.2018.09.001.
Hirose S, Enta Y, Ishii K, Inoue A, Nakashima M, Nomura T, et al. En face view of the transcatheter heart valve from deep right-anterior-oblique cranial position for coronary access after transcatheter aortic valve implantation: a case series. Eur Heart J Case Rep. 2022;6:ytac059. https://doi.org/10.1093/ehjcr/ytac059.
Article PubMed PubMed Central Google Scholar
Nakashima M, Miyasaka M, Satomi N, Kobayashi Y, Hirose S, Saigan M, et al. Implications of the en face view of transcatheter heart valves for coronary access post-TAVR. JACC Cardiovasc Interv. 2023;16:3049–51. https://doi.org/10.1016/j.jcin.2023.08.038.
Blanke P, Weir-McCall JR, Achenbach S, Delgado V, Hausleiter J, Jilaihawi H, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR): an expert consensus document of the society of cardiovascular computed tomography. JACC Cardiovasc Imaging. 2019;12:1–24. https://doi.org/10.1016/j.jcmg.2018.12.003.
Tarantini G, Nai Fovino L, Scotti A, Massussi M, Cardaioli F, Rodinò G, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: the ALIGN-ACCESS study. Circ Cardiovasc Interv. 2022;15: e011045. https://doi.org/10.1161/circinterventions.121.011045.
Article CAS PubMed Google Scholar
Costa G, Sammartino S, Strazzieri O, Motta S, Frittitta V, Dipietro E, et al. Coronary cannulation following TAVR using self-expanding devices with commissural alignment: the RE-ACCESS 2 study. JACC Cardiovasc Interv. 2024;17:727–37. https://doi.org/10.1016/j.jcin.2023.12.015.
Nai Fovino L, Scotti A, Massussi M, Cardaioli F, Rodinò G, Matsuda Y, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc. 2020;9: e016446. https://doi.org/10.1161/jaha.120.016446.
Article PubMed PubMed Central Google Scholar
Sharma T, Krishnan AM, Lahoud R, Polomsky M, Dauerman HL. National trends in TAVR and SAVR for patients with severe isolated aortic stenosis. J Am Coll Cardiol. 2022;80:2054–6. https://doi.org/10.1016/j.jacc.2022.08.787.
Sugiyama Y, Moriyama N, Miyashita H, Yokoyama H, Ochiai T, Shishido K, et al. Long-term assessment of survival after transcatheter aortic valve implantation— insights from the international transcatheter aortic valve implantation registry. Circ J. 2024;88:462–71. https://doi.org/10.1253/circj.CJ-23-0593.
Stefanini GG, Cerrato E, Pivato CA, Joner M, Testa L, Rheude T, et al. Unplanned percutaneous coronary revascularization after TAVR: a multicenter international registry. JACC Cardiovasc Interv. 2021;14:198–207. https://doi.org/10.1016/j.jcin.2020.10.031.
Rogers T, Greenspun BC, Weissman G, Torguson R, Craig P, Shults C, et al. Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients. JACC Cardiovasc Interv. 2020;13:726–35. https://doi.org/10.1016/j.jcin.2020.01.202.
Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary. angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol. 2015;104:632–9.
Boukantar M, Gallet R, Mouillet G, et al. Coronary procedures after TAVI with the self-expanding aortic bioprosthesis medtronic corevalve, not an easy matter. J Interv Cardiol. 2017;30:56–62.
Zivelonghi C, Pesarini G, Scarsini R, et al. Coronary catheterization and percutaneous interventions after transcatheter aortic valve implantation. Am J Cardiol. 2017;120:625–31.
Htun WW, Grines C, Schreiber T. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a medtronic self-expandable bioprosthetic valve. Catheter Cardiovasc Interv. 2018;91:1339–44.
Ferreira-Neto AN, Puri R, Asmarats L, et al. Clinical and technical characteristics of coronary angiography and percutaneous coronary interventions performed before and after transcatheter aortic valve replacement with a balloon-expandable valve. J Interv Cardiol. 2019;2019:3579671.
Article PubMed PubMed Central Google Scholar
Tanaka A, Jabbour RJ, Testa L, et al. Incidence, technical safety, and feasibility of coronary angiography and intervention following self-expanding transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2019;20:371–5.
Abdelghani M, Landt M, Traboulsi H, Becker B, Richardt G. Coronary access after TAVR with a self-expanding bioprosthesis: insights from computed tomography. JACC Cardiovasc Interv. 2020;13:709–22.
Comments (0)